Glenmede Trust’s Ligand Pharmaceuticals LGND Stock Holding History

Glenmede Trust’s Portfolio LGND Stock Details LGND Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-3,677	Closed	-$300K	–	1317
2021 Q2	$300K	Sell	3,677 -80	-2%	-$6.53K	﹤0.01%	1032
2021 Q1	$357K	Sell	3,757 -2,750	-42%	-$261K	﹤0.01%	934
2020 Q4	$403K	Buy	6,507 +560	+9%	+$34.7K	﹤0.01%	896
2020 Q3	$352K	Buy	5,947 +667	+13%	+$39.5K	﹤0.01%	883
2020 Q2	$368K	Buy	5,280 +1,332	+34%	+$92.8K	﹤0.01%	843
2020 Q1	$256K	Hold	3,948	–	–	﹤0.01%	1101
2019 Q4	$256K	Buy	3,948 +328	+9%	+$21.3K	﹤0.01%	1101
2019 Q3	$224	Sell	3,620 -2,018	-36%	-$125	﹤0.01%	1127
2019 Q2	$400	Buy	5,638 +351	+7%	+$25	﹤0.01%	965
2019 Q1	$413	Sell	5,287 -443,832	-99%	-$34.7K	﹤0.01%	936
2018 Q4	$38K	Buy	449,119 +166,595	+59%	+$14.1K	0.19%	159
2018 Q3	$48.4M	Sell	282,524 -287,544	-50%	-$49.2M	0.19%	160
2018 Q2	$73.7M	Sell	570,068 -59,802	-9%	-$7.73M	0.33%	70
2018 Q1	$53.8M	Hold	629,870	–	–	0.22%	119
2017 Q4	$53.8M	Buy	629,870 +128,304	+26%	+$11M	0.22%	119
2017 Q3	$42.6M	Buy	501,566 +500,373	+41,942%	+$42.5M	0.19%	162
2017 Q2	$78K	Hold	1,193	–	–	﹤0.01%	1452
2017 Q1	$78K	Buy	1,193 +74	+7%	+$4.84K	﹤0.01%	1452
2016 Q4	$70K	Hold	1,119	–	–	﹤0.01%	1498
2016 Q3	$71K	Buy	1,119 +48	+4%	+$3.05K	﹤0.01%	1484
2016 Q2	$79K	Sell	1,071 -255	-19%	-$18.8K	﹤0.01%	1419
2016 Q1	$87K	Buy	1,326 +222	+20%	+$14.6K	﹤0.01%	1359
2015 Q4	$73K	Hold	1,104	–	–	﹤0.01%	1446
2015 Q3	$58K	Buy	1,104 +62	+6%	+$3.26K	﹤0.01%	1539
2015 Q2	$64K	Buy	1,042 +75	+8%	+$4.61K	﹤0.01%	1546
2015 Q1	$46K	Hold	967	–	–	﹤0.01%	1712
2014 Q4	$32K	Buy	967 +209	+28%	+$6.92K	﹤0.01%	1881
2014 Q3	$22K	Sell	758 -80	-10%	-$2.32K	﹤0.01%	1932
2014 Q2	$32K	Buy	838 +521	+164%	+$19.9K	﹤0.01%	1754
2014 Q1	$13K	Hold	317	–	–	﹤0.01%	1990
2013 Q4	$10K	Hold	317	–	–	﹤0.01%	1993
2013 Q3	$8K	Hold	317	–	–	﹤0.01%	1969
2013 Q2	$7K	Buy	+317	New	+$7K	﹤0.01%	1930